These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32978515)

  • 1. Spinal muscular atrophy - the dawning of a new era.
    Farrar MA; Kiernan MC
    Nat Rev Neurol; 2020 Nov; 16(11):593-594. PubMed ID: 32978515
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradigm shift in the era of disease-modifying therapies for Spinal Muscular Atrophy type 1: respiratory challenges and opportunities.
    Xiao L; Chiang J; Amin R
    Sleep Med; 2021 Oct; 86():113-115. PubMed ID: 34253462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expert consensus on rehabilitation management of the spinal muscular atrophy].
    ;
    Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):883-887. PubMed ID: 36038296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain.
    Skedgel C
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):3-5. PubMed ID: 34935104
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of spinal muscular atrophy in European countries: A call to action.
    Vázquez-Costa JF; Martínez-Moreno M; Madruga-Garrido M; Munell F; Nascimento A; Pitarch-Castellano I; Pascual-Pascual SI; Povedano M; Cattinari MG
    Eur J Neurol; 2022 Nov; 29(11):3475-3477. PubMed ID: 35971869
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy for spinal muscular atrophy: hope and caution.
    Goemans N
    Lancet Neurol; 2021 Apr; 20(4):251-252. PubMed ID: 33743228
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.
    Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K
    Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.
    Kirschner J; Butoianu N; Goemans N; Haberlova J; Kostera-Pruszczyk A; Mercuri E; van der Pol WL; Quijano-Roy S; Sejersen T; Tizzano EF; Ziegler A; Servais L; Muntoni F
    Eur J Paediatr Neurol; 2021 Jan; 30():103-104. PubMed ID: 33640649
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect on maximal mouth opening in children with spinal muscular atrophy treated with onasemnogene abeparvovec.
    Beri N; Kapoor L; Parashar D; Mundada V
    Arch Dis Child; 2023 Oct; 108(10):866-867. PubMed ID: 37553206
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene replacement therapy for spinal muscular atrophy unmasking occult hepatitis C in a pediatric patient.
    Lakhotia A; Turek G; Green J; Khan M
    Muscle Nerve; 2022 Jan; 65(1):E2-E3. PubMed ID: 34644404
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy and rehabilitation of the floppy infant.
    Eng GD
    R I Med J (1976); 1989 Oct; 72(10):367-70. PubMed ID: 2595191
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the problem of spinal muscular atrophy resembling progressive muscular dystrophy (Kugelberg-Welander's juvenile muscular atrophy)].
    GOLDSZTAJN M; ZEBROWSKI S
    Neurol Neurochir Psychiatr Pol; 1962; 12():669-73. PubMed ID: 13948828
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial progressive bulbar-spinal muscular atrophy.
    MAGEE KR
    Neurology; 1960 Mar; 10():295-305. PubMed ID: 14419783
    [No Abstract]   [Full Text] [Related]  

  • 14. Another milestone in childhood spinal muscular atrophy.
    Wokke JH
    Lancet Neurol; 2017 Jul; 16(7):491-492. PubMed ID: 28460890
    [No Abstract]   [Full Text] [Related]  

  • 15. New Frontiers in the Treatment of Spinal Muscular Atrophy.
    Power CL; O'Rourke DJ
    Ir Med J; 2018 Mar; 111(3):705. PubMed ID: 30376223
    [No Abstract]   [Full Text] [Related]  

  • 16. Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.
    Bertini E; Gadisseux JL; Palmieri G; Ricci E; Di Capua M; Ferriere G; Lyon G
    Am J Med Genet; 1989 Jul; 33(3):328-35. PubMed ID: 2801766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for Spinal Muscular Atrophy.
    Mendell JR
    N Engl J Med; 2018 Feb; 378(5):487. PubMed ID: 29394473
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy for Spinal Muscular Atrophy.
    Whittaker HT; Michell-Robinson MA
    N Engl J Med; 2018 Feb; 378(5):487. PubMed ID: 29394306
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy for Spinal Muscular Atrophy.
    Finkel RS; Farwell W
    N Engl J Med; 2018 Feb; 378(5):487-488. PubMed ID: 29385371
    [No Abstract]   [Full Text] [Related]  

  • 20. Infantile spinal progressive muscular atrophy in twins.
    POIRIER R; CORBET RC; BUCKWOLD AE
    Can Med Assoc J; 1951 Oct; 65(4):342-3. PubMed ID: 14879299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.